Survey: China, Malaysia demonstrate strong pharma growth

05/14/2013 | BioSpectrum Asia · BioSpectrum Asia

Despite slowing fiscal growth in China, government investments are ensuring that the country's pharmaceutical industry will continue to expand and attract private investment. Malaysia, too, is rapidly becoming a center of pharmaceutical and medical device manufacturing, with estimates that the medtech market there will hit $2.8 billion in four years. The assessments of both countries come from the BioSpectrum Asia Top 20 Survey.

View Full Article in:

BioSpectrum Asia · BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT